Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Usp42 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | increases expression | ISO | Usp42 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of USP42 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Usp42 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Usp42 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of USP42 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Usp42 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of USP42 mRNA | CTD | PMID:25270620 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of USP42 mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | USP42 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of USP42 mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA | CTD | PMID:28628672 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of USP42 mRNA | CTD | PMID:28959563 | aristolochic acid A | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of USP42 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to USP42 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases methylation | ISO | USP42 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of USP42 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | USP42 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of USP42 3' UTR | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of USP42 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of USP42 mRNA | CTD | PMID:30816183 more ... | caffeine | decreases phosphorylation | ISO | USP42 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of USP42 protein | CTD | PMID:35688186 | chlorpyrifos | decreases expression | ISO | Usp42 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of USP42 mRNA | CTD | PMID:37019170 | cisplatin | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of USP42 mRNA | CTD | PMID:27594783 | copper(II) sulfate | increases expression | ISO | USP42 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of USP42 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | USP42 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of USP42 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | USP42 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of USP42 mRNA | CTD | PMID:20106945 and PMID:25562108 | dexamethasone | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of USP42 mRNA | CTD | PMID:29803840 | formaldehyde | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of USP42 mRNA | CTD | PMID:20655997 | FR900359 | affects phosphorylation | ISO | USP42 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of USP42 protein | CTD | PMID:37730182 | indometacin | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA | CTD | PMID:28628672 | lead diacetate | increases expression | ISO | Usp42 (Mus musculus) | 6480464 | lead acetate results in increased expression of USP42 mRNA | CTD | PMID:20542052 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of USP42 mRNA | CTD | PMID:33484710 | paracetamol | affects expression | ISO | Usp42 (Mus musculus) | 6480464 | Acetaminophen affects the expression of USP42 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of USP42 mRNA | CTD | PMID:21420995 | pentachlorophenol | increases expression | ISO | Usp42 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of USP42 mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Usp42 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | ISO | Usp42 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of USP42 mRNA | CTD | PMID:21318169 | pirinixic acid | multiple interactions | ISO | Usp42 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of USP42 mRNA] | CTD | PMID:21318169 | SB 431542 | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of USP42 mRNA | CTD | PMID:21297353 | temozolomide | increases expression | ISO | USP42 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of USP42 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of USP42 mRNA | CTD | PMID:34492290 | torcetrapib | increases expression | ISO | USP42 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of USP42 mRNA | CTD | PMID:23228038 | trichostatin A | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of USP42 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA | CTD | PMID:27188386 | triticonazole | decreases expression | EXP | | 6480464 | triticonazole results in decreased expression of USP42 mRNA | CTD | PMID:36084822 | tungsten | decreases expression | ISO | Usp42 (Mus musculus) | 6480464 | Tungsten results in decreased expression of USP42 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | USP42 (Homo sapiens) | 6480464 | Urethane results in increased expression of USP42 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | USP42 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of USP42 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | USP42 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of USP42 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | USP42 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of USP42 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | USP42 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA | CTD | PMID:27188386 | |